Sign up here and take full advantage of MicrobiomePost‘s features.
Sign up

Engineering Live biotherapeutics to treat complex respiratory diseases

Maria Lluch Senar, Founder and Chief Scientific Officer at Pulmobiotics SL, discusses the research on engineering Live Biotherapeutics in order to expose antigens or deliver therapeutic agents to treat complex respiratory diseases.

During the 8th annual Microbiome Movement Drug Development Europe, held in Barcelona (Spain), Microbiomepost sat down with Maria Lluch Senar, Founder and Chief Scientific Officer at Pulmobiotics SL, to discuss the research on engineering Live Biotherapeutics in order to expose antigens or deliver therapeutic agents to treat complex respiratory diseases.

Most recent

HCPs Area

Industry

  • Read more about LBP

MicrobiomePost.com provides qualified scientific updates to healthcare professionals and to anyone who wants to know more about the microbiome

Published by Clorofilla Srl

Facebook-f Linkedin Twitter Youtube
© 2016-2024 Clorofilla Scientific Publishing

Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963

© ALL RIGHTS RESERVED

Read MicrobiomePost’s Privacy Policy